So Nader took the part they didn't intentionally screw up on the old BLA, sent it back to the FDA. Meanwhile the clinical data is in limbo with Amarex. On top of that we don't know how that data actually looks, if that data is as Nader advertised and if CYDY has the money to satisfy the debt that allows the data to be released to them.
If it turns out that data is a mess CYDY could be in a turn around and have to do their PIII all over again.
That's why I don't like these piecemeal submissions. Nader did it last time and hid the fact he knew he was submitting an incomplete application.
On approval of CYDY BLA the stock price will go BALLISTIC! Two more CytoDyn ballistic missiles were also launched yesterday in the two peer review submissions. Six months from now one or both might be approved and published causing more explosions in the upward value of CytoDyn. Time to buy more Cyto-RocketDyn!
Market Data 
Markets 
AI
